Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell

Molecular Human Reproduction

Volumn 12, Issue 3, 2006, Pages 157-167

  Wahab, M ^a   Taylor, A H ^b   Pringle, J H ^c   Thompson, J ^b   Al Azzawi, Farooka ^d  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Endometrium; HRT; Metalloproteinases; Progesterone; Trimegestone

Indexed keywords

ESTRADIOL; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERSTITIAL COLLAGENASE; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY; STROMELYSIN; TRIMEGESTONE; VIMENTIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUTEAL PHASE; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STROMA CELL;

ADULT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MENSTRUATION; MIDDLE AGED; MIFEPRISTONE; PROGESTERONE; PROGESTINS; PROMEGESTONE; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 33645805876     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal014     Document Type: Article

References (64)

1. Agoulnik IU, Krause WC, Bingman WE III, Rahman HT, Amrikachi M, Ayala GE and Weigel NL (2003) Repressors of androgen and progesterone receptor action. J Biol Chem 278,31136-31148.
2. Al-Azzawi F, Wabab M, Sami S, Proudler AJ, Thompson J and Stevenson J (2004) Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women. Climacteric 7,292-300.
3. Al-Azzawi F, Wabab M, Thompson J, Whitehead M and Thompson W (1999) Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: A dose-ranging study. Hum Reprod 14,636-641.
4. Baulieu EE, Ulmann A and Philibert D (1987) Contragestion by antiprogestin RU 486: A review. Arch Gynecol Obstet 241,73-85.
5. Bicknell GR, Shaw JA, Pringle JH and Furness PN (1996) Amplification of specific mRNA from a single human renal glomerulus, with an approach to the separation of epithelial cell mRNA. J Pathol 180,188-193.
6. Bouchoux F, Cerede E and Philibert D (1995) Measurement of the relative binding affinity of RU27987 to recombinant human steroid receptors: progestogen, glucocorticoid, androgen and oestrogen determination of the binding parameters of RU27987 and progesterone for the recombinant human progesterone receptor. 1995; 93/5353/PH data on file at Roussel-Uclaf.
7. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72,248-254.
8. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM and Osteen KG (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92,7362-7366.
9. Casslen B, Urano S and Ny T (1992) Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thromb Res 66,75-87.
10. Comet PB, Galant C, Eeckhout Y, Courtoy PJ, Marbaix E and Henriet P (2005) Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab 90,1001-1011.
11. Dai B, Cao Y, Liu W, Li S, Yang Y, Chen D and Duan E (2003) Dual roles of progesterone in embryo implantation in mouse. Endocrine 21,123-132.
12. Eckert RL and Katzenellenbogen BS (1981) Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level by natural and synthetic estrogens in vitro. J Clin Endocrinol Metab 52,699-708.
13. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA and Eisen AZ (1986) Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261,6600-6005.
14. Gompel A, Malet C, Spritzer P, Lalardrie JP, Kuttenn F and Mauvais-Jarvis P (1986) Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63,1174-1180.
15. Grubb G, Spielmann D, Pickar J and Constantine G (2003) Clinical experience with trimegestone as a new progestin in HRT. Steroids 68,921-926.
16. Hall LL, Bicknell GR, Primrose L, Pringle JH, Shaw JA and Furness PN (1998) Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. Biotechniques 24,652-658.
17. Hamilton PW (1995) Designing a morphometric study. In Allen DC (ed.), Quantitative Clinical Pathology. Blackwell Science, Oxford, pp. 311-315.
18. Hampton AL, Nie G and Salamonsen LA (1999) Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. Mol Hum Reprod 5,365-371.
19. Hatayama H, Kanzaki H, Iwai M, Fujimoto M, Higuchi T, Kojima K, Nakayama H, Mori T and Fujita J (1994) Progesterone enhances macrophage colony-stimulating factor production in human endometrial cells in culture. Endocrinology 135,1921-1927.
20. Hickey M and Fraser IS (2001) The causes and management of endometrial breakthrough bleeding. Reprod Med Rev 9,153-171.
21. Hirata S, Shoda T, Kato J and Hoshi K (2002) Novel isoforms of the mRNA for human female sex steroid hormone receptors. J Steroid Biochem Mol Biol 83,25-30.
22. Hulboy DL, Rudolph LA and Matrisian LM (1997) Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3,27-45.
23. Jeziorska M, Nagase H, Salamonsen LA and Woolley DE (1996) Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil 107,43-51.
24. Kamelle S, Sienko A and Benbrook DM (2002) Retinoids and steroids regulate menstrual phase histological features in human endometrial organotypic cultures. Fertil Steril 78,596-602.
25. Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N and Honjo H (2001) Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 16,51-55.
26. Kokrine L, Marbaix E, Henriet P, Donnez J, Eeckhout Y and Couirtoy PJ (1996) Focal cellular origin and regulation of interstitial collagenase (Matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 109,2151-2160.
27. Laird SM, Tuckerman EM, Saravelos H and Li TC (1996) The production of tumour necrosis factor alpha (TNF-alpha) by human endometrial cells in culture. Hum Reprod 11,1318-1323.
28. Marbaix E, Donnez J, Courtoy PJ and Eeckhout Y (1992) Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 89,11789-11793.
29. Marbaix E, Kokorine I, Donnez J, Eeckhout Y and Courtoy PJ (1996) Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum Reprod 11,134-143.
30. Marbaix E, Kokorine L, Henriet P, Donnez J, Courtoy PJ and Eeckhout Y (1995) The expression of the interstitial collagenase in human endometrium is controlled by progesterone and estradiol and is related to menstruation. Biochem 1305,1027-1030.
31. Oliveira-Ribeiro M, Petta CA, De Angelo Andrade LAL, Bahamondez L and Hidalgo MM (2004) Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system. Hum Reprod 19,1778-1784.
32. Osteen KG, Bruner-Tran KL and Eisenberg E (2005) Reduced progesterone action during endometrial maturation: A potential risk factor for the development of endometriosis. Fertil Steril 83,529-537.
33. Perrot-Applanat M (2004) Immunolocalization of endometrial matrix metalloproteases and their implication in bleeding. Mt Endocrinol Reprod 6,173-177.
34. Pilka R and Hrachovec P (2003) Metalloproteinases matrix and menstruation review. Ceska Gynekol 68,36-40.
35. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE and Salamonsen LA (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79,530-536.
36. Robin-Jagerschmidt C, Wurtz J-M, Guillot B, Gofflo D, Benhamou B, Vergezac A, Ossart C, Moras D and Philibert D (2000) Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Mol Endocrinol 14,1028-1037.
37. Robbins A and Spitz IM (1996) Mifepristone: Clinical pharmacology. Clin Obstet Gynecol 39,436-450.
38. Salamonsen LA, Butt AR, Hammond FR, Garcia S and Zhang J (1997) Production of endometrial matrix metalloproteinase, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 82,1409-1415.
39. Salamonsen LA and Woolley DE (1996) Matrix metalloproteinases as mediators of reproductive function. Hum Reprod 11, 124-133.
40. Schatz F, Papp C, Aigner S, Krikun G, Hausknecht V and Lockwood CJ (1997) Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression. J Clin Endocrinol Metab 82,188-193.
41. Seval Y, Akkoyunlu G, Demir R and Asar M (2004) Distribution patterns of matrix metalloproteinase (MMP) -2 and - 9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem 106,353-362.
42. Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H, Oda T, Katsuma Y, Koyama N and Nakamura Y (1996) Expression of beta 1 integrins in human endometrial stromal and decidual cells. J Clin Endocrinol Metabol 81,1533-1540.
43. Singer CF, Marbaix E, Lemoine P, Courtoy PJ and Eeckhout Y (1999) Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 359,40-45.
44. Sitruk-Ware R (2004a) New progestogens: A review of their effects in perimenopausal and postmenopausal women. Drug Aging 21,865-883.
45. Sitruk-Ware R (2004b) Pharmacological profile of progestins. Maturitas 47,277-283.
46. Sivridis E and Giatromanolaki A (2004) New insights into the normal menstrual cycle-regulatory molecules. Histol Histopathol 19,511-516.
47. Skinner JL, Riley SC, Gebbie AE, Glasier AF and Critchley HO (1999) Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 14,793-799.
48. Smith SK (1996) Vascular endothelial growth factor and the endometrium. Hum Reprod 11,56-61.
49. Song LN, Coghlan M and Gelmann EP (2004) Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol Endocrinol 18,70-85.
50. Tabibzadeh S (1996) The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod 2,77-92.
51. Taylor AH, Al-Azzawi F, Pringle JH and Bell SC (2002) Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides. Anticancer Res 22,3993-4004.
52. Taylor AH, Guzail M, Wahab M, Thompson JR and Al-Azzawi F (2005) Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle. Histochem Cell Biol 123,463-474.
53. Taylor AH, McParland PC, Taylor DJ and Bell SC (2006) The progesterone receptor in human term amniochorion and placenta is isoform C. Endocrinology 147,687-693.
54. Taylor RN, Savouret J-F, Vaisse C, Vigne J-L, Ryan I, Hornung D, Seppala M and Migrom E (1998) Promegestone (R5020) and mifepristone (RU486) both function as progestastional agonists of human glycodelin gene expression in isolated epithelial cells. J Clin Endocrinol Metab 83,4006-4012.
55. Treloar SA, Zhao ZZ, Armitage T, Duffy DL, Wicks J, O'Connor DTO, Martin NG and Montgomery GW (2005) Association between polymorphisms in the progesterone receptor gene and endometriosis. Mol Hum Reprod 11,641-647.
56. Vigano P, Di Blasio, A, Dell Antonio G and Vignali M (1993) Culture of human endometrial cells: A new simple technique to completely separate epithelial cells. Acta Obstet Gynecol Scand 72,87-92.
57. Vincent AJ, Malakooti N, Zhang J, Rogers PA, Affandi B and Salamonsen LA (1999) Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 14,807-815.
58. Vincent AJ and Salamonsen LA (2000) The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 15,135-143.
59. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G and Salamonsen LA (2000) Matrix metalloproteinase-1 and - 3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod 15,123-130.
60. Wahab M, Thompson J and Al-Azzawi F (1999a) The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium, of the natural cycle: A dose-ranging study. Hum Reprod 14,1201-1206.
61. Wahab M, Thompson J, Hamid B, Deen S and Al-Azzawi F (1999b) Endometrial histomorphometry of trimegestone-based sequential hormone replacement therapy: A weighted comparison with the endometrium of the natural cycle. Hum Reprod 14,2609-2618.
62. Wang W and Passaniti A (1999) Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NFkappaB-dependent mechanism. J Cell Biochem 73,321-331.
63. Wiegratz I and Kuhl H (2004) Progestogen therapies: Differences in clinical effects? Trends Endocrinol Metab 15,277-285.
64. Winneker RC, Bitran D and Zhang Z (2003) The preclinical biology of a new potent and selective progestin: Trimegestone. Steroids 68,915-920.